Canaccord Genuity Upgrades Momenta Pharmaceuticals (MNTA) to Buy

Go back to Canaccord Genuity Upgrades Momenta Pharmaceuticals (MNTA) to Buy

Teva (TEVA) Comments on COPAXONE Litigation (MYL) (MNTA)

July 26, 2013 1:26 PM EDT

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Southern District of New York in the appeal filed by Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA)/Sandoz Inc. and Mylan Laboratories Inc. (Nasdaq: MYL)/Natco Pharmaceuticals regarding the validity and infringement of four patents for Tevas... More

Streetinsider.com's Hot Lunchtime Reads 07/26: (MNTA) (EXPE) (PX) (ZNGA)

July 26, 2013 12:14 PM EDT

The following is a list of notable articles to help get you through the lunch hour:Momenta Pharma (MNTA) Jumps, Teva (TEVA) Sinks ->... More

UPDATE: Momenta Pharma (MNTA) Jumps, Teva (TEVA) Sinks

July 26, 2013 11:18 AM EDT

(Updated - July 26, 2013 11:26 AM EDT)

Momenta Pharma (Nasdaq: MNTA) stock was active mid-day on Friday, gaining 3%. Teva Pharmaceutical (NYSE: TEVA) stock sank. The moves appear related to a mixed court ruling that will block generic versions of multiple... More